Doxycycline Hyclate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Doxycycline Hyclate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DOXYCYCLINE HYCLATE DESCRIPTION


Doxycycline Hyclate






CLINICAL PHARMACOLOGY






Microbiology


Gram-Negative Bacteria

















Gram-Positive Bacteria






Other Microorganisms

Susceptibility tests: Diffusion techniques:



Dilution techniques:




INDICATIONS & USAGE



Treatment:

  • ●     Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae.
  • ●     Respiratory tract infections caused by Mycoplasma pneumoniae.
  • ●     Lymphogranuloma venereum caused by Chlamydia trachomatis.
  • ●     Psittacosis (omithosis) caused by Chlamydia trachomatis.
  • ●     Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence.
  • ●     Inclusion conjunctivitis caused by Chlamydia trachomatis.
  • ●     Uncomplicated urethral, endocervical or rectal infections in adults caused by Chlamydia trachomatis.
  • ●     Nongonococcal urethritis caused by Ureaplasma urealyticum.
  • ●     Relapsing fever due to Borrelia recurrentis.

  • ●     Chancroid caused by Haemophilius ducreyl.
  • ●     Plague due to Tersinia pestis (formerly Pasturella pestis).
  • ●     Tularemia due to Francisella tularensis (formerly Pasturella tularensis).
  • ●     Cholera caused by Vibrio cholerae (formerly Vibrio comma).
  • ●     Campylobacter fetus infections caused by Campylobacter fetus (formerly Vibrio fetus).
  • ●     Brucellosis due to Brucella species (in conjunction with streptomycin).
  • ●     Bartonellosis due to Bartonella bacilliformis.
  • ●     Granuloma inguinale caused by Calymmatobacterium granulomatis.


  • ●     Escherichia coli.
  • ●     Enterobacter aerogenes (formerly Aerobacter aerogenes).
  • ●     Shigella species.
  • ●     Acinetobacter species (formerly Mima species and Herellea species).
  • ●     Respiratory tract infections caused by Haemophilius influenzae.
  • ●     Respiratory tract and urinary tract infections caused by Klebsiella species.

  • ●     Upper respiratory infections caused by Streptococcus pneumoniae (formerly Diplococcus pneumoniae).


  • ●     Uncomplicated gonorrhea caused by Neisseria gonorrhoeae.
  • ●     Syphillis caused by Treponema pallidum.
  • ●     Yaws caused by Treponema pertenue.
  • ●     Listeriosis due to Listeria monocytogenes.
  • ●     Vincent's infection caused by Fusobacterium fusiforme.
  • ●     Actinomycosis caused by Actinomyces israelli.
  • ●     Infections caused by Clostridium species.



Prophylaxis:
DOSAGE AND ADMINISTRATIONInformation for PatientsPRECAUTIONS

DOXYCYCLINE HYCLATE CONTRAINDICATIONS



WARNINGS










PRECAUTIONS

General






INFORMATION FOR PATIENTS










WARNINGS
ADVERSE REACTIONS
Drug Interactions
Drug Interactions












WARNINGS
ADVERSE REACTIONS
Drug Interactions
Drug Interactions




LABORATORY TESTS




DRUG INTERACTIONS









DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY




Nonteratogenic Effects: (See Warnings).

LABOR & DELIVERY



NURSING MOTHERS

WARNINGS

Pediatric Use
WARNINGSDOSAGE AND ADMINISTRATION

DOXYCYCLINE HYCLATE ADVERSE REACTIONS


DOSAGE AND ADMINISTRATION
WARNINGS
WARNINGS


PRECAUTIONSGeneral


DOXYCYCLINE HYCLATE ADVERSE REACTIONS


DOSAGE AND ADMINISTRATION
WARNINGS
WARNINGS


PRECAUTIONSGeneral


OVERDOSAGE



DOSAGE & ADMINISTRATION






ADVERSE REACTIONS














HOW SUPPLIED










ANIMAL PHARMACOLOGY & OR TOXICOLOGY





REFERENCES







PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Doxycycline Hyclate

Doxycycline Hyclate

Doxycycline Hyclate CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-049(NDC:0143-3142)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Doxycycline Hyclate DOXYCYCLINE HYCLATE 100 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
lactose monohydrate
MAGNESIUM STEARATE
FD&C BLUE NO. 1
SILICON DIOXIDE
SODIUM LAURYL SULFATE
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
blue 11 mm WW;3142 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-049-60 60 in 1 VIAL

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA062396 2012-01-12


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.